Table 2_Alleviating psychosocial distress in drug-resistant tuberculosis: a pre-post study

Chengdu Public Health Clinical Medical Center recruited 74 patients with drug-resistant tuberculosis between January and December 2021. This pilot study assessed changes in loneliness, depression, anxiety, sleep quality, and medication adherence before and after a 12-week telephone-delivered motivational interviewing intervention. The dataset, authored by Fanghui Xie and last updated in May 2026, contains results from validated psychological scales.

Use Cases

• Analyzing the efficacy of telephone-delivered psychological interventions based on pre-post changes in UCLA-LS, SDS, and HAMA scores.
• Modeling the relationship between psychosocial distress and medication adherence based on binary adherence outcomes and psychological scale data.
• Evaluating the impact of motivational interviewing on sleep quality based on Pittsburgh Sleep Quality Index (PSQI) scores.
• Conducting pilot feasibility studies for scalable mental health support in clinical populations based on the single-group pre-post design.

Strengths

• Data is derived from a study with 74 participants, providing a specific sample size.
• Results show statistically significant changes in primary outcomes, including a 30.9% decline in depressive symptoms (SDS).
• Assessments were conducted using validated instruments (UCLA-LS, SDS, HAMA, PSQI).

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• The single-group pre-post design limits causal inference, as noted in the study conclusion.
• Row count is unknown, which may limit suitability assessment for certain analyses.

Provenance

Source

figshare

Collection Method

Single-group pre-post study with assessments at baseline (Week 0) and post-intervention (Week 16).

Time Range

Data collection occurred between January and December 2021.

Freshness

Last updated 2026-05-08 05:46:50; freshness should be verified.

Geography

Patients were recruited from the tuberculosis wards of Chengdu Public Health Clinical Medical Center, China.